• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Saturday 07/21/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

SKLN

  • 9:37 AM

    MINNEAPOLIS, Feb. 27, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical (NASDAQ:SKLN), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today it has formed a wholly owned subsidiary, TumorGenesis Inc., to develop the next generation or patient derived (“PDx”) tumor models for precision cancer therapy and drug development. The Company formed TumorGenesis Inc. to develop a new, rapid approach to growing tumors in the laboratory, which essentially

    Read more
  • 9:16 AM

    RECENT NEWS – – – – – – – –   Change in ticker symbol reflects Company’s market positioning as leaders in the AI for precision medicine market MINNEAPOLIS, Feb. 02, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc, formerly Skyline Medical Inc, (NASDAQ:SKLN) (NASDAQ:AIPT) (“Precision Therapeutics” or the “Company”), is pleased to announce that its NASDAQ Capital Market ticker symbol will change from ‘SKLN’ to ‘AIPT’ effective February 2, 2018. The new symbol has been chosen to align the Company’s symbol

    Read more
  • 2:20 PM

    Recent News – – – – – Company appoints Jean-Paul Rasschaert as Vice President of International Sales MINNEAPOLIS, Jan. 26, 2018 (GLOBE NEWSWIRE) — Skyline Medical Inc (NASDAQ:SKLN) (“Skyline” or the “Company”), today announced that it has opened new European headquarters in Belgium and appointed Jean-Paul Rasschaert as Vice President of International Sales to drive international sales for the STREAMWAY System. Based in Brussels, Mr. Rasschaert will be responsible for overseeing sales of the Company’s FDA-approved STREAMWAY® System for automated, direct-to-drain medical

    Read more
  • 12:04 PM

    Conference call begins at 11:00 a.m. Eastern time tomorrow August 15 MINNEAPOLIS, Aug. 14, 2017, SKLN, (GLOBE NEWSWIRE) — Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications (“STREAMWAY”), reports financial results for the three and six months ended June 30, 2017 and provides a business update. Highlights of the second quarter of 2017 and recent weeks include: Signed a definitive agreement to merge with CytoBioscience Received CE mark for the STREAMWAY

    Read more
  • 2:44 PM

    MINNEAPOLIS, Nov. 15, 2016, SKLN, (GLOBE NEWSWIRE) — Skyline Medical Inc. (SKLN) (“Skyline” or “the Company”), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports financial results for the three and nine months ended September 30, 2016. Highlights of the third quarter of 2016 and recent weeks include: Signed an agreement with GLG Pharma, Inc. to be the exclusive distributor of the STREAMWAY System in the U.K., Poland and certain Central European countries Entered into a

    Read more
  • 4:27 PM

    Skyline to be exclusive reseller MINNEAPOLIS, Sept. 21, 2016, SKLN, (GLOBE NEWSWIRE) — Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing of a partnership and exclusive reseller agreement with GLG Pharma, LLC (“GLG”). Under the terms of the agreement, GLG intends to develop rapid diagnostic tests that utilize fluid and tissue collected by the STREAMWAY System during procedures. Skyline Medical will issue common stock to

    Read more
Public Wire Banner